Co-Diagnostics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CODX Nasdaq 3840 co-dx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Co-Diagnostics, Inc.

Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe - Oct 8th, 2026 7:26 am
Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease - Oct 7th, 2026 7:00 am
Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development - Oct 6th, 2026 7:00 am
Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week - Sep 23rd, 2026 7:00 am
Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation - Sep 21st, 2026 7:00 am
Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026 - Sep 17th, 2026 7:00 am
Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola - Sep 16th, 2026 6:45 am
Co-Diagnostics to Hold Press Conference - Sep 15th, 2026 2:15 pm
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India - Sep 3rd, 2026 7:00 am
Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base - Sep 1st, 2026 7:30 am
Co-Dx (CODX) Q2 2026 Earnings Call Transcript - Aug 20th, 2026 5:50 pm
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event - Aug 18th, 2026 7:30 am
Co-Diagnostics, Inc. Q2 2026 Earnings Call Summary - Aug 14th, 2026 6:30 am
Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FDA Submission Milestone and ... - Aug 13th, 2026 11:03 pm
Co-Diagnostics Reports Second Quarter 2026 Financial Results - Aug 13th, 2026 2:01 pm
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test - Aug 6th, 2026 7:30 am
OraSure Technologies Q2 Earnings Call Highlights - Aug 5th, 2026 10:03 pm
Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast - Jul 30th, 2026 7:00 am
EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test - Jul 29th, 2026 9:30 pm
Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies - Jul 28th, 2026 6:00 am